Financial News Feed

Today AGRX ranks # as BUY CANDIDATE.
Today AGRX ranks # as BUY CANDIDATE.

AGRX stock Agile Therapeutics

AGRX stock
Agile Therapeutics

Agile Therapeutics Inc. (NASDAQ:AGRX) and Tricida Inc. (NASDAQ:TCDA) compete with each other in the Drugs – Generic sector. We will analyze and contrast their dividends, analyst recommendations, ins...

Read more

Checking in on shares of Agile Therap (AGRX), we can see that the current opinion signal on the stock for today’s session is 64% Buy. Looking back at the last month, the opinion signal reads 40% Buy...

Read more

Looking at the numbers for Agile Therap (AGRX), we can now see that the Piotroski F Score reading is at five or lower. Tracking this signal, investors may be looking for signs of possible financial we...

Read more

Agile Therap (AGRX) shares are on close watch heading into the week as the price has moved above the Balance Step indicator, revealing a potential near-term bullish uptrend. The Balance Step formula i...

Read more

Sentiment for AGILE THERAPEUTICS INC (NASDAQ:AGRX) AGILE THERAPEUTICS INC (NASDAQ:AGRX) institutional sentiment decreased to 0.46 in 2018 Q4. Its down -0.29, from 0.75 in 2018Q3. The ratio dropped, as...

Read more

Agile Therapeutics Inc. (NASDAQ:AGRX) and Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) compete with each other in the Drugs – Generic sector. We will analyze and contrast their profitability, analyst...

Read more

Both Agile Therapeutics Inc. (NASDAQ:AGRX) and Mallinckrodt Public Limited Company (NYSE:MNK) are Drugs - Generic companies, competing one another. We will...

Read more

Algorx Pharmaceuticals Inc (AGRX) investors sentiment decreased to 0.46 in 2018 Q4. It’s down -0.29, from 0.75 in 2018Q3. The ratio worsened, as 6 institutional investors opened new or increased equ...

Read more

Analysts expect Capstone Mining Corp. (TSE:CS) to report $0.03 EPS on April, 23.They anticipate $0.00 EPS change or 0.00% from last quarter’s $0.03 EPS. T_CS’s profit would be $11.99M giving it 5....

Read more

Checking in on the signals for Agile Therap (AGRX), we have recently recorded the Chaikin Oscillator above zero. Traders may be watching for possible bullish momentum on the stock. Investors who are n...

Read more

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Agile Therapeutics, Inc. NasdaqCM:AGRX is 3.384491. A lower price to bo...

Read more

Investors might be looking to rebuild the portfolio as we move into the second half of the year. New investors can be tempted to try to maximize returns by owning one specific sector or be exposed to ...

Read more

We are contrasting Agile Therapeutics Inc. (NASDAQ:AGRX) and MYOS RENS Technology Inc. (NASDAQ:MYOS) on their analyst recommendations, institutional ownership,...

Read more

Investors are delving into the details on shares of Agile Therap (AGRX). The share price has climbed the ladder moving past the Stochtastic Momentum Index of +40, indicating possible overbought territ...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank